A section of the Congress leadership questioned the drug regulator’s “premature” approval for Bharat Biotech’s Covaxin, pointing out that the indigenously-developed Covid-19 vaccine was yet to complete the final stage of human clinical trials.
#CapitalTV #CapitalTVOnline
Congress Raises questions Over Govt’s Nod to Covaxin | Anju Pankaj
